Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 17, 2024

SELL
$114.26 - $136.0 $4,341 - $5,168
-38 Reduced 2.01%
1,855 $228,000
Q3 2023

Oct 31, 2023

SELL
$122.0 - $145.31 $4,514 - $5,376
-37 Reduced 1.92%
1,893 $245,000
Q2 2023

Jul 14, 2023

BUY
$122.5 - $147.16 $236,425 - $284,018
1,930 New
1,930 $239,000
Q3 2022

Oct 25, 2022

SELL
$126.59 - $161.18 $927,271 - $1.18 Million
-7,325 Closed
0 $0
Q2 2022

Aug 24, 2022

SELL
$141.59 - $168.66 $67,113 - $79,944
-474 Reduced 6.08%
7,325 $1.14 Million
Q1 2022

May 06, 2022

BUY
$129.64 - $160.7 $1.01 Million - $1.25 Million
7,799 New
7,799 $1.21 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Cordatus Wealth Management LLC Portfolio

Follow Cordatus Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordatus Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cordatus Wealth Management LLC with notifications on news.